Estrella Immunopharma, Inc. Quarterly Return On Assets in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Estrella Immunopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2022 to Q3 2024.
  • Estrella Immunopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -134 %, a 125% decline year-over-year.
  • Estrella Immunopharma, Inc. annual Return On Assets for 2024 was -58.6 %, a 10.1% increase from 2023.
  • Estrella Immunopharma, Inc. annual Return On Assets for 2023 was -65.2 %, a 2296% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -134 -74.6 -125% Jul 1, 2024 Sep 30, 2024
Q2 2024 -58.6 -8.98 -18.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -28.4 +3.28 +10.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -46 -29.2 -174% Oct 1, 2023 Dec 31, 2023
Q3 2023 -59.7 -53.8 -907% Jul 1, 2023 Sep 30, 2023
Q2 2023 -49.7 -49.8 -30757% Apr 1, 2023 Jun 30, 2023
Q1 2023 -31.6 Jan 1, 2023 Mar 31, 2023
Q4 2022 -16.8 Oct 1, 2022 Dec 31, 2022
Q3 2022 -5.93 Jul 1, 2022 Sep 30, 2022
Q2 2022 0.16 Apr 1, 2022 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.